SG Americas Securities LLC Has $7 Million Stock Position in Revvity Inc. $RVTY

SG Americas Securities LLC lessened its stake in shares of Revvity Inc. (NYSE:RVTY) by 35.2% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 79,874 shares of the company’s stock after selling 43,299 shares during the period. SG Americas Securities LLC owned about 0.07% of Revvity worth $6,998,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. CYBER HORNET ETFs LLC acquired a new position in shares of Revvity during the 2nd quarter worth approximately $32,000. Cromwell Holdings LLC grew its stake in shares of Revvity by 141.4% in the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after buying an additional 198 shares in the last quarter. MUFG Securities EMEA plc bought a new position in shares of Revvity in the second quarter valued at $34,000. Headlands Technologies LLC bought a new position in shares of Revvity in the second quarter valued at $49,000. Finally, Los Angeles Capital Management LLC acquired a new position in Revvity during the fourth quarter worth $51,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

RVTY has been the subject of a number of recent analyst reports. Weiss Ratings upgraded shares of Revvity from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday. The Goldman Sachs Group lowered their price objective on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 14th. TD Cowen upped their target price on shares of Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Stifel Nicolaus cut their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. Finally, Barclays lifted their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Four investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $108.33.

Revvity Stock Performance

Shares of NYSE:RVTY opened at $112.98 on Monday. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $118.30. The company’s 50 day moving average price is $97.46 and its two-hundred day moving average price is $97.74. The firm has a market cap of $12.60 billion, a PE ratio of 54.06, a PEG ratio of 2.47 and a beta of 1.11. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The company had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities research analysts predict that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity’s payout ratio is currently 13.40%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.